Rezolute, Inc. announced that the Data Monitoring Committee (DMC) has reviewed the open-label arm of its Phase 3 sunRIZE study for the treatment of congenital hyperinsulinism with ersodetug in infants ...
Inventiva (IVA) announced the recommendation from the fifth scheduled meeting of the Data Monitoring Committee, or DMC, to continue the NATiV3 Phase 3 clinical trial evaluating lanifibranor in ...
The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data. The recommendation was based on ...
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift the clinical hold concerning the nebulizer device used ...
Phase 3 TransportNPC study to continue based on the independent DMC review of safety and efficacy data at prespecified 48-week interim analysis Data on the investigational candidate Trappsol® Cyclo™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results